Cardinal Health Reports Fourth-quarter and Year-end Results for Fiscal Year 2018

Go back to Cardinal Health Reports Fourth-quarter and Year-end Results for Fiscal Year 2018

Cardinal Health (CAH) PT Lowered to $56 at RBC Capital

August 7, 2018 7:56 AM EDT

RBC Capital lowered its price target on Cardinal Health (NYSE: CAH) to $56.00 (from $61.00) while maintaining a Sector Perform rating.

Analyst George Hill said the near-term outlook sees more challenges than opportunities.

... More

Cardinal Health (CAH) Tops Q4 EPS by 8c, Offers FY19 Guidance

August 6, 2018 6:57 AM EDT

Cardinal Health (NYSE: CAH) reported Q4 EPS of $1.01, $0.08 better than the analyst estimate of $0.93. Revenue for the quarter came in at $35 billion versus the consensus estimate of $34.38 billion.

GUIDANCE:

Cardinal Health sees FY2019 EPS of $4.90-$5.15, versus the consensus of... More